Trial NCT01011439

View at ClinicalTrials.gov 
Org. Study IDs: CDKO-125a-006
Secondary IDs: 2009-014338-79

Last trial update was posted on 2019-02-06

MeSH Interventions

Maleic acid

MeSH Conditions

Carcinoma Thymoma

Other Conditions

Thymic Carcinoma

Stopping Reasons

For the 2 last patients still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID